Skip to main content
. 2022 Oct 13;37(12):4304–4315. doi: 10.1111/jocs.17020

Table 2a.

Comparison of overall clinical outcomes and resource utilization between patients with and without tMCS

Variables No MCS MCS Total Unadjusted 95% confidence interval Adjusted 95% confidence interval
(Weighted n = 1,297,075) (Weighted n = 86,445) (Weighted n = 1,383,520) OR/mean difference Lower Upper p Value OR/AMD Lower Upper p Value
Inpatient mortality 19,840 (1.53) 13,525 (15.66) 33,365 (2.41) 11.95 11.31 12.63 <.001 9.71 9.11 10.36 <.001
LOS (mean [SE]) days 8.5 (0.04) 14.4 (0.13) 8.87 (0.04) 5.90 5.66 6.14 <.001 4.54 4.32 4.76 <.001
Inflation‐ adjusted cost, US $ (mean [SE]) 51,357.68 (295.55) 93,040.02 (1038.34) 53,960.9 (321.91) 41,682.34 39,916.23 43,448.45 <.001 35,814.54 34,259.50 37,369.57 <.001
Disposition to SNF/ICF or other facilty 245,405 (19.36) 26,035 (37.26) 271,440 (20.3) 2.47 2.38 2.57 .001 2.70 2.59 2.81 <.001

Abbreviations: AMD, adjusted mean differences; LOS, length of stay; OR, odd ratio; tMCS, temporary mechanical circulatory support.